Actinium Pharmaceuticals vs Lisata Therapeutics
ATNM and LSTA side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ATNM and LSTA compare
Actinium Pharmaceuticals is the larger company, worth 4.5 times as much as Lisata Therapeutics ($42.4M against $9.4M).
Actinium Pharmaceuticals scores higher on the StockData Score (10 against 6 for Lisata Therapeutics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ATNM | LSTA |
|---|---|---|
| Size and price | ||
| Market cap | $42.4M | $9.4M |
| Share price | $1.35 | $1.04 |
| Change, 1 year | 6.3% | −50.9% |
| Change, 5 years | −81.5% | −92.9% |
| Beta (5Y) | 1.38 | −1.59 |
| Employees | 25 | 21 |
| StockData Score | ||
| Total score | 10 (better) | 6 |
| Valuation score | 4 (better) | 1 |
| Growth score | 0 | 0 |
| Performance score | 1 (better) | 0 |
| Health score | 5 | 5 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 3.8× | – |
| P/S | – | 93.7× |
| P/B | 1.4× | 1.1× (better) |
| EV/EBITDA | 0.6× | – |
| FCF yield | – | −131% |
| Fair value | $7.16 | – |
| Margin of safety | 81.1% | – |
| Growth | ||
| Revenue growth (TTM) | – | −90.7% |
| Profitability | ||
| Operating margin | – | −16427% |
| Net margin | – | −14621% |
| FCF margin | – | −12323% |
| Return on equity | 45.9% (better) | −99.9% |
| Return on invested capital | – | −1645% |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 4.08 (better) | 3.69 |
| Altman Z-score | −9.28 (better) | −74.81 |
| Piotroski F-score | 2 (better) | 1 |
| Dividends and buybacks | ||
| Buyback yield | – | −6.3% |
| Shareholder yield | 0.00% (better) | −6.3% |
| Ownership | ||
| Held by institutions | 16.8% | 12.1% |
| Held by insiders | 5.9% | 11.6% |
| Short interest, % of float | 2.0% | 0.43% |
Go deeper
- ATNM stock overview
- ATNM income statement
- ATNM valuation and score
- LSTA stock overview
- LSTA income statement
- LSTA valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.